Barclays
PTLA

Barclays’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,306,377
Closed -$23.5M 4094
2020
Q2
$23.5M Buy
1,306,377
+1,186,891
+993% +$21.4M 0.02% 406
2020
Q1
$851K Sell
119,486
-56,406
-32% -$402K ﹤0.01% 1831
2019
Q4
$4.2M Buy
175,892
+61,692
+54% +$1.47M ﹤0.01% 1359
2019
Q3
$3.06M Buy
114,200
+56,603
+98% +$1.52M ﹤0.01% 1422
2019
Q2
$1.56M Buy
57,597
+34,197
+146% +$928K ﹤0.01% 2000
2019
Q1
$812K Buy
23,400
+1,480
+7% +$51.4K ﹤0.01% 2300
2018
Q4
$428K Sell
21,920
-34,907
-61% -$682K ﹤0.01% 2339
2018
Q3
$1.51M Buy
56,827
+39,050
+220% +$1.04M ﹤0.01% 1994
2018
Q2
$671K Sell
17,777
-221,323
-93% -$8.35M ﹤0.01% 2100
2018
Q1
$7.81M Buy
239,100
+151,666
+173% +$4.95M 0.01% 785
2017
Q4
$4.26M Sell
87,434
-2,128
-2% -$104K ﹤0.01% 934
2017
Q3
$4.84M Sell
89,562
-31,166
-26% -$1.68M 0.01% 819
2017
Q2
$6.78M Buy
120,728
+33,965
+39% +$1.91M 0.01% 682
2017
Q1
$3.4M Buy
86,763
+58,444
+206% +$2.29M ﹤0.01% 928
2016
Q4
$636K Buy
28,319
+17,219
+155% +$387K ﹤0.01% 1718
2016
Q3
$251K Sell
11,100
-26,565
-71% -$601K ﹤0.01% 2027
2016
Q2
$889K Buy
37,665
+30,086
+397% +$710K ﹤0.01% 1491
2016
Q1
$152K Buy
7,579
+1,661
+28% +$33.3K ﹤0.01% 2176
2015
Q4
$303K Sell
5,918
-13,733
-70% -$703K ﹤0.01% 1876
2015
Q3
$825K Buy
19,651
+14,934
+317% +$627K ﹤0.01% 1510
2015
Q2
$212K Buy
4,717
+2,899
+159% +$130K ﹤0.01% 2056
2015
Q1
$68K Sell
1,818
-4,338
-70% -$162K ﹤0.01% 2635
2014
Q4
$173K Sell
6,156
-597
-9% -$16.8K ﹤0.01% 2435
2014
Q3
$170K Sell
6,753
-4,684
-41% -$118K ﹤0.01% 2388
2014
Q2
$331K Buy
11,437
+4,269
+60% +$124K ﹤0.01% 2185
2014
Q1
$180K Buy
7,168
+5,598
+357% +$141K ﹤0.01% 2436
2013
Q4
$40K Buy
1,570
+1,209
+335% +$30.8K ﹤0.01% 3484
2013
Q3
$9K Sell
361
-147
-29% -$3.67K ﹤0.01% 3685
2013
Q2
$12K Buy
+508
New +$12K ﹤0.01% 3848